Early detection and staging of chronic liver diseases with a protein MRI contrast agent

Early diagnosis and noninvasive detection of liver fibrosis and its heterogeneity remain as major unmet medical needs for stopping further disease progression toward severe clinical consequences. Here we report a collagen type I targeting protein-based contrast agent (ProCA32.collagen1) with strong...

Descripción completa

Detalles Bibliográficos
Autores principales: Salarian, Mani, Turaga, Ravi Chakra, Xue, Shenghui, Nezafati, Maysam, Hekmatyar, Khan, Qiao, Jingjuan, Zhang, Yinwei, Tan, Shanshan, Ibhagui, Oluwatosin Y., Hai, Yan, Li, Jibiao, Mukkavilli, Rao, Sharma, Malvika, Mittal, Pardeep, Min, Xiaoyi, Keilholz, Shella, Yu, Liqing, Qin, Gengshen, Farris, Alton Brad, Liu, Zhi-Ren, Yang, Jenny J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820552/
https://www.ncbi.nlm.nih.gov/pubmed/31664017
http://dx.doi.org/10.1038/s41467-019-11984-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820552/
https://www.ncbi.nlm.nih.gov/pubmed/31664017
http://dx.doi.org/10.1038/s41467-019-11984-2

Ejemplares similares